Amphotercin B Lipid Complex Treatment of a Leukemic Child wlth Disseminated Fusarrium solani Infection

Clinical Pediatrics

Volumn 35, Issue 5, 1996, Pages 257-260

  Patterson, Thomas S ^a   Barton, Leslie L ^a   Shehab, Ziad M ^a   Hutter, John J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; FEMALE; FUSARIUM SOLANI; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; NEUTROPENIA; SINUSITIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD, PRESCHOOL; DERMATOMYCOSES; DRUG COMBINATIONS; DRUG RESISTANCE, MICROBIAL; FEMALE; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MYCOSES; NEUTROPENIA; PARANASAL SINUS DISEASES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS;

EID: 0029975180     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289603500505     Document Type: Article

References (31)

1. Rabodinirina M, Piens MA, Monier MF, et al. Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis. 1994; 13: 152-161.
2. Anaissie E, Kantarian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine. 1988; 67: 77-83.
3. Barrios NJ, Kirkpatrick DV, Murciano A, et al. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Onco L 1990; 12: 319-324.
4. Gates C, Pinney RJ. Amphotericin B and its delivery by liposomal and lipid formulations. J Clin Pharm Ther. 1993; 18: 147-153.
5. Lopez-Berestien G, Fainstein V, Hopfer R, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985; 151: 704-710.
6. Agamanolis DP, Kalwinsky DK, KrillJr CE, et al. Fusarium meningoencephalitis in a child with acute leukemia. Neuropediatrics. 1991; 22: 110-112.
7. Zaias N. Superficial white onychomycosis. Sabouraudia. 1966; 5: 99-103.
8. Zapater RC, Arrechea A. Mycotic keratitis by Fusarium. A review and report of two cases. Ophthalmologica. 1975; 170: 1-12.
9. Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis. 1994; 18: 585-588.
10. Steinberg GK, Britt RH, Enzmann DR, et al. Fusarium brain abscess. Case Report. J Neurosurg. 1983; 58: 598-601.
11. Cho CT, Vats TS, Lowman JT, et al. Fusarium solani infection during treatment for acute leukemia. J Pediatr. 1973; 83: 1028-1031.
12. Hsu CM, Lee P, Chen J, et al. Fatal Fusarium endocarditis complicated by hemolytic anemia and thrombocytopenia in an infant. PediatrInfectDisj 1994; 13: 1146-1147.
13. Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J RheumatoL 1983; 10: 151-153.
14. Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983; 99: 334-337.
15. Englehard D, Eldor A, Polachek I, et al. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma. 1993; 9: 385-392.
16. Madhavan M, Ratnakar C, Veliath AJ, et al. Primary disseminated fusarial infection. J Postgrad Med. 1992; 68: 143-144.
17. Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol OtoL 1992; 106: 733-736.
18. Gamis AS, Gudnason T, Giebink GS, Ramsay NKC. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis. 1991; 13: 1077-1088.
19. Holmberg K, Meyer, RD. Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press; 1989: 8-8, 55-55.
20. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994; 28 (Suppl 1):7-15.
21. Lupinetti FM, Giller RH, Trigg ME. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg. 1990; 49: 991-992.
22. Wolff MA, Ramphal R. Use of amphotericin B lipid complex for treatment of disseminated cutaneous Fusarium infection in a neutropenic patient. CLD. 1995; 20: 1568-1569.
23. Summerbell RC, Richardson SE, Kane J. Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. J Clin Microbiol. 1988; 26: 82-87.
24. Chaulk CP, Smith PW, Feagler JR, et al. Fungemia due to Fusarium solani in an immunocompromised child. Pediatr Infect Dis. 1986; 5: 363-366.
25. DeMuri GP, Hostetter MK. Resistance to antifungal agents. Pediatr Clin North Am. 1995; 42: 665-685.
26. Jones RS, Barman A, Suh B, et al. Successful treatment of aspergillus vertebral osteomyelitis with amphotericin B lipid complex. Infect Dis Clin Pract. 1995; 4: 237-239.
27. Hospenthal DR, Byrd JC, Weiss RB. Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex. Med Pediatr OncoL 1995; 25: 119-122.
28. Janknegt R, Siem de Marie, BakkerWoudenberg IAJM, Crommelin DJA. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet. 1992; 23: 279-291.
29. Kline S, Larsen TA, Fieber L, et al. Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex. Clin Infect Dis. 1995; 21: 1154-1158.
30. Anaissie EJ, Ramphal R. Efficacy and safety of amphotericin B lipid complex (ABLC) in the treatment of patients with life-threatening fusariosis. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994. Abstract M87, p. 248-248.
31. Walsh TJ, Hiemenz JW, Seibel N, Anaissie EJ. Amphotericin B lipid complex in the treatment of 228 cases of invasive mycosis. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994. Abstract M69, p. 247-247.